Business / Finance

RSS

BioAtla, Pfizer sign license and option agreement for new class of antibody therapeutics

BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.

8 Dec 2015

Comfort Medical acquires Medical Direct Club

Comfort Medical, LLC today announced its acquisition of Medical Direct Club, LLC, the third largest direct-to-consumer supplier of urological catheters and supplies in the U.S.

7 Dec 2015

Merus reports revenues of $49.0 million for fiscal 2015

Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.

7 Dec 2015

Excellence in graduate student research, third annual Kaluza prizes

Beckman Coulter collaborated with the American Society for Cell Biology to sponsor the Third Annual ASCB Kaluza Prizes for academic excellence.

From Beckman Coulter Life Sciences - Flow Cytometry 7 Dec 2015

Memorandum of understanding signed between Cell Therapy Catapult and Kanagawa Prefecture

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the signing of a memorandum of understanding with the Kanagawa Prefecture of Japan.

30 Nov 2015

Human Longevity announces acquisition of Cypher Genomics

Human Longevity, Inc., the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.

30 Nov 2015

SuperCom awarded $8 million in new contracts

SuperCom Ltd., a leading provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, today announced that it has been awarded new contracts, totaling approximately $8 million. The Company expects to deliver and recognize the full value of the orders during the first half of 2016.

30 Nov 2015

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

30 Nov 2015

Mallinckrodt sells CMDS business to Guerbet for $270 million

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.

28 Nov 2015

Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Lannett Company, Inc. today announced that it has completed the acquisition of Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A.

27 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, has granted Getinge Infection Control AB, a global leader in infection control solutions, exclusive global distributor rights to its FDA-cleared, STERIZONE VP4 Sterilizer for US$7.5 million, plus performance minimums

25 Nov 2015

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.

25 Nov 2015

BioPlast Manufacturing acquires Kord-Valmark

BioPlast Manufacturing, a manufacturer of plastic components used primarily for the medical research, clinical diagnostic and biotech environments, announced today that it has acquired Kord-Valmark, a leading manufacturer of quality petri dishes. This acquisition is aligned with BioPlast Manufacturing's strategy to offer clients a platform of products that are designed and tested by scientists for scientists and manufactured with the highest quality.

24 Nov 2015

TeamHealth successfully completes acquisition of IPC Healthcare

Team Health Holdings, Inc., a leading physician services organization, today announced it has successfully completed its acquisition of IPC Healthcare, Inc., a national acute hospitalist and post-acute provider organization.

23 Nov 2015

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

ProMetic Life Sciences Inc. announced today that it has entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived Inter-alpha Inhibitor Proteins.

19 Nov 2015

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.

18 Nov 2015

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.

17 Nov 2015

Corning signs agreement to become global distributor for popular BioCision products

Corning Incorporated and BioCision, LLC today announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.

17 Nov 2015

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology. Specific terms of the agreement were not disclosed.

15 Nov 2015

Business / Finance

BioAtla, Pfizer sign license and option agreement for new class of antibody therapeutics

Comfort Medical acquires Medical Direct Club

Merus reports revenues of $49.0 million for fiscal 2015

Excellence in graduate student research, third annual Kaluza prizes

Memorandum of understanding signed between Cell Therapy Catapult and Kanagawa Prefecture

Human Longevity announces acquisition of Cypher Genomics

SuperCom awarded $8 million in new contracts

Heptares announces strategic drug discovery collaboration with Pfizer

Mallinckrodt sells CMDS business to Guerbet for $270 million

Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Can-Fite BioPharma reports financial results, provides updates on drug development programs

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

BioLight signs joint financing agreement with two Asia-based venture capital firms

BioPlast Manufacturing acquires Kord-Valmark

TeamHealth successfully completes acquisition of IPC Healthcare

ProMetic, ProThera form strategic partnership to develop and commercialize Inter-alpha Inhibitor Proteins

Cell Therapy Catapult initiates construction for cell and gene therapy manufacturing centre

China Pharma's revenue decreases 19.5% to $4.8 million in Q3 2015

Corning signs agreement to become global distributor for popular BioCision products

ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News